Tricyclic antidepressant (sedating)
Trimipramine
Brand names: Surmontil
Adult dose
Dose: Initial 50–75mg PO ON, max 300mg/day
Route: PO
Frequency: ON
Clinical pearls
- Depression with insomnia/anxiety
- Highly sedating — bedtime only
Contraindications
- Recent MI
- Arrhythmias
- Mania
- Severe hepatic impairment
- Concurrent MAOI
Side effects
- Sedation (very high)
- Anticholinergic
- Postural hypotension
- QT prolongation
- Cardiotoxicity in overdose
- Weight gain
Interactions
- MAOIs
- CNS depressants
- QT-prolonging drugs
- SSRIs
Monitoring
- Mood
- ECG
- Suicidality
Reference: BNF; NICE NG222; https://bnf.nice.org.uk/drugs/trimipramine/. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF
- Alcohol Withdrawal Management · NICE CG115 2010 / BNF
- Eating Disorder Assessment · NICE CG9 2017 / MARSIPAN
- Serotonin syndrome · Hunter criteria (Dunkley 2003); TOXBASE/NPIS; BNF